Inovio Pharmaceuticals Inc (INO)

5.45
0.09 1.68
NASDAQ : Health Care
Prev Close 5.36
Open 5.30
Day Low/High 5.28 / 5.56
52 Wk Low/High 4.50 / 11.69
Volume 838.53K
Avg Volume 2.15M
Exchange NASDAQ
Shares Outstanding 90.23M
Market Cap 498.05M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

North Korea puts a worrying wrinkle in the markets. We add to 2 portfolio positions.

Inovio Earnings Don't Look So Good Under the Hood

Expenses rose, revenue was bloated by a deferred lump sum and cash and equivalents has declined.

Inovio Pharmaceuticals Stock Sees Short Interest Drop 20.5%

Inovio Pharmaceuticals Stock Sees Short Interest Drop 20.5%

The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 2,217,694 share decrease in total short interest for Inovio Pharmaceuticals Inc. , to 8,603,835, a decrease of 20.49% since 07/14/2017.

Antares and Amplify Brands Reports; Plus Other Earnings News

Five portfolio names report today. Here is what we have seen, and what two expect after the closing bell.

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

Investors Need to Closely Watch Mario Draghi's Speech at Jackson Hole: Market Recon

What are the chances of a Draghi dovish surprise? I wouldn't bet the farm on anything.

Stocks Under $10 Weekly Summary

It was a rough week for the portfolio.

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

Jim Cramer says investors should step away from these near-term shenanigans and focus on the fundamentals.

Chevron, Universal Display, Dynavax Technologies, Schlumberger: 'Mad Money' Lightning Round

Chevron, Universal Display, Dynavax Technologies, Schlumberger: 'Mad Money' Lightning Round

Jim Cramer is bullish on Chevron, Universal Display, Dynavax Technologies, and Schlumberger.

Adding to 2 Positions

We'll purchase more shares of Pixelworks and Inovio ahead of their quarterly results next week.

Stocks Under $10 Weekly Summary

We made several trades and price target changes during a mixed week for the portfolio.

Raising Our Price Target on 2 Holdings, Cutting It on One

Sometimes, changing the price target is better than selling (or buying).

Stocks Under $10 Weekly Summary

The portfolio has some high fliers and underperformers last week as we head into the heart of earnings season.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

Identifying this week's bullish and bearish reversal patterns.

September 15th Options Now Available For Inovio Pharmaceuticals (INO)

September 15th Options Now Available For Inovio Pharmaceuticals (INO)

Investors in Inovio Pharmaceuticals Inc. saw new options begin trading today, for the September 15th expiration.

Oversold Conditions For Inovio Pharmaceuticals (INO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Biotech Movers: Sarepta, Inovio, Mylan

Biotech Movers: Sarepta, Inovio, Mylan

Sarepta Therapeutics, Inovio Pharmaceuticals and Mylan were among the biotech movers in premarket trading on July 20.

Adding to a Name on Weakness

It's hard to ignore INO's price this far below our cost basis.

Biotech Movers: Vertex Continues to Move on Data for CF Regimen

Biotech Movers: Vertex Continues to Move on Data for CF Regimen

Vertex Pharmaceuticals, FibroGen and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading trading on July 19.

A Pharma Pairs Trade

We'll take some profits in AcelRx and lower our cost basis on Inovio.

Stocks Under $10 Weekly Summary

We brought a new name into the portfolio last week as the Fed's comments helped lift the market.

Adding to a Biotech Position

We'll lower our cost basis on Inovio Pharmaceuticals.

Stocks Under $10 Weekly Summary

We made no trades during the holiday-shortened week, but added to our natural hedge today.

Biotech Movers: Exelixis, Omeros, Inovio

Biotech Movers: Exelixis, Omeros, Inovio

Exelixis, Omeros and Inovio Pharmaceuticals were among the biotech movers in premarket trading on July 10.

Inovio's DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation

Inovio's DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation

Inovio dMAbĀ® product induces complete protection against lethal challenge with influenza A & B viruses in published preclinical study